img

Global Pharma Ophthalmic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharma Ophthalmic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pharma Ophthalmic report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma Ophthalmic market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Glaucoma and Dry eye syndrome are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharma Ophthalmic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharma Ophthalmic key manufacturers include Novartis, Allergan, Roche, Valeant, Regeneron, Santen, Bayer, Pfizer and Senju, etc. Novartis, Allergan, Roche are top 3 players and held % sales share in total in 2022.
Pharma Ophthalmic can be divided into Retinal disorders drugs, Allergic, inflammatory and infective drugs, Glaucoma drugs and Dry eye drugs, etc. Retinal disorders drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharma Ophthalmic is widely used in various fields, such as Glaucoma, Dry eye syndrome, Retinal diseases and Other ophthalmic indications, etc. Glaucoma provides greatest supports to the Pharma Ophthalmic industry development. In 2022, global % sales of Pharma Ophthalmic went into Glaucoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma Ophthalmic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
Segment by Type
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs

Segment by Application


Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pharma Ophthalmic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma Ophthalmic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma Ophthalmic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharma Ophthalmic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma Ophthalmic introduction, etc. Pharma Ophthalmic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharma Ophthalmic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pharma Ophthalmic Market Overview
1.1 Pharma Ophthalmic Product Overview
1.2 Pharma Ophthalmic Market Segment by Type
1.2.1 Retinal disorders drugs
1.2.2 Allergic, inflammatory and infective drugs
1.2.3 Glaucoma drugs
1.2.4 Dry eye drugs
1.2.5 Other ophthalmic drugs
1.3 Global Pharma Ophthalmic Market Size by Type
1.3.1 Global Pharma Ophthalmic Market Size Overview by Type (2018-2034)
1.3.2 Global Pharma Ophthalmic Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pharma Ophthalmic Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pharma Ophthalmic Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pharma Ophthalmic Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pharma Ophthalmic Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Type (2018-2024)
2 Global Pharma Ophthalmic Market Competition by Company
2.1 Global Top Players by Pharma Ophthalmic Sales (2018-2024)
2.2 Global Top Players by Pharma Ophthalmic Revenue (2018-2024)
2.3 Global Top Players by Pharma Ophthalmic Price (2018-2024)
2.4 Global Top Manufacturers Pharma Ophthalmic Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pharma Ophthalmic Market Competitive Situation and Trends
2.5.1 Pharma Ophthalmic Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pharma Ophthalmic Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharma Ophthalmic as of 2022)
2.7 Date of Key Manufacturers Enter into Pharma Ophthalmic Market
2.8 Key Manufacturers Pharma Ophthalmic Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pharma Ophthalmic Status and Outlook by Region
3.1 Global Pharma Ophthalmic Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pharma Ophthalmic Historic Market Size by Region
3.2.1 Global Pharma Ophthalmic Sales in Volume by Region (2018-2024)
3.2.2 Global Pharma Ophthalmic Sales in Value by Region (2018-2024)
3.2.3 Global Pharma Ophthalmic Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pharma Ophthalmic Forecasted Market Size by Region
3.3.1 Global Pharma Ophthalmic Sales in Volume by Region (2024-2034)
3.3.2 Global Pharma Ophthalmic Sales in Value by Region (2024-2034)
3.3.3 Global Pharma Ophthalmic Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pharma Ophthalmic by Application
4.1 Pharma Ophthalmic Market Segment by Application
4.1.1 Glaucoma
4.1.2 Dry eye syndrome
4.1.3 Retinal diseases
4.1.4 Other ophthalmic indications
4.2 Global Pharma Ophthalmic Market Size by Application
4.2.1 Global Pharma Ophthalmic Market Size Overview by Application (2018-2034)
4.2.2 Global Pharma Ophthalmic Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pharma Ophthalmic Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pharma Ophthalmic Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pharma Ophthalmic Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pharma Ophthalmic Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Application (2018-2024)
5 North America Pharma Ophthalmic by Country
5.1 North America Pharma Ophthalmic Historic Market Size by Country
5.1.1 North America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pharma Ophthalmic Sales in Volume by Country (2018-2024)
5.1.3 North America Pharma Ophthalmic Sales in Value by Country (2018-2024)
5.2 North America Pharma Ophthalmic Forecasted Market Size by Country
5.2.1 North America Pharma Ophthalmic Sales in Volume by Country (2024-2034)
5.2.2 North America Pharma Ophthalmic Sales in Value by Country (2024-2034)
6 Europe Pharma Ophthalmic by Country
6.1 Europe Pharma Ophthalmic Historic Market Size by Country
6.1.1 Europe Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pharma Ophthalmic Sales in Volume by Country (2018-2024)
6.1.3 Europe Pharma Ophthalmic Sales in Value by Country (2018-2024)
6.2 Europe Pharma Ophthalmic Forecasted Market Size by Country
6.2.1 Europe Pharma Ophthalmic Sales in Volume by Country (2024-2034)
6.2.2 Europe Pharma Ophthalmic Sales in Value by Country (2024-2034)
7 Asia-Pacific Pharma Ophthalmic by Region
7.1 Asia-Pacific Pharma Ophthalmic Historic Market Size by Region
7.1.1 Asia-Pacific Pharma Ophthalmic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pharma Ophthalmic Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pharma Ophthalmic Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pharma Ophthalmic Forecasted Market Size by Region
7.2.1 Asia-Pacific Pharma Ophthalmic Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pharma Ophthalmic Sales in Value by Region (2024-2034)
8 Latin America Pharma Ophthalmic by Country
8.1 Latin America Pharma Ophthalmic Historic Market Size by Country
8.1.1 Latin America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pharma Ophthalmic Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pharma Ophthalmic Sales in Value by Country (2018-2024)
8.2 Latin America Pharma Ophthalmic Forecasted Market Size by Country
8.2.1 Latin America Pharma Ophthalmic Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pharma Ophthalmic Sales in Value by Country (2024-2034)
9 Middle East and Africa Pharma Ophthalmic by Country
9.1 Middle East and Africa Pharma Ophthalmic Historic Market Size by Country
9.1.1 Middle East and Africa Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pharma Ophthalmic Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pharma Ophthalmic Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pharma Ophthalmic Forecasted Market Size by Country
9.2.1 Middle East and Africa Pharma Ophthalmic Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pharma Ophthalmic Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Pharma Ophthalmic Products Offered
10.1.5 Novartis Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Allergan Pharma Ophthalmic Products Offered
10.2.5 Allergan Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Pharma Ophthalmic Products Offered
10.3.5 Roche Recent Development
10.4 Valeant
10.4.1 Valeant Company Information
10.4.2 Valeant Introduction and Business Overview
10.4.3 Valeant Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Valeant Pharma Ophthalmic Products Offered
10.4.5 Valeant Recent Development
10.5 Regeneron
10.5.1 Regeneron Company Information
10.5.2 Regeneron Introduction and Business Overview
10.5.3 Regeneron Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Regeneron Pharma Ophthalmic Products Offered
10.5.5 Regeneron Recent Development
10.6 Santen
10.6.1 Santen Company Information
10.6.2 Santen Introduction and Business Overview
10.6.3 Santen Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Santen Pharma Ophthalmic Products Offered
10.6.5 Santen Recent Development
10.7 Bayer
10.7.1 Bayer Company Information
10.7.2 Bayer Introduction and Business Overview
10.7.3 Bayer Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bayer Pharma Ophthalmic Products Offered
10.7.5 Bayer Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Pharma Ophthalmic Products Offered
10.8.5 Pfizer Recent Development
10.9 Senju
10.9.1 Senju Company Information
10.9.2 Senju Introduction and Business Overview
10.9.3 Senju Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Senju Pharma Ophthalmic Products Offered
10.9.5 Senju Recent Development
10.10 Akorn
10.10.1 Akorn Company Information
10.10.2 Akorn Introduction and Business Overview
10.10.3 Akorn Pharma Ophthalmic Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Akorn Pharma Ophthalmic Products Offered
10.10.5 Akorn Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pharma Ophthalmic Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pharma Ophthalmic Industrial Chain Analysis
11.4 Pharma Ophthalmic Market Dynamics
11.4.1 Pharma Ophthalmic Industry Trends
11.4.2 Pharma Ophthalmic Market Drivers
11.4.3 Pharma Ophthalmic Market Challenges
11.4.4 Pharma Ophthalmic Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pharma Ophthalmic Distributors
12.3 Pharma Ophthalmic Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Retinal disorders drugs
Table 2. Major Company of Allergic, inflammatory and infective drugs
Table 3. Major Company of Glaucoma drugs
Table 4. Major Company of Dry eye drugs
Table 5. Major Company of Other ophthalmic drugs
Table 6. Global Pharma Ophthalmic Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Pharma Ophthalmic Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Pharma Ophthalmic Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Pharma Ophthalmic Sales by Type (2018-2024) & (US& Million)
Table 10. Global Pharma Ophthalmic Market Share in Value by Type (2018-2024)
Table 11. Global Pharma Ophthalmic Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Pharma Ophthalmic Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Pharma Ophthalmic Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Pharma Ophthalmic Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Pharma Ophthalmic Sales Market Share in Value by Type (2024-2034)
Table 16. Global Pharma Ophthalmic Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Pharma Ophthalmic Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Pharma Ophthalmic Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Pharma Ophthalmic Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Pharma Ophthalmic Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Pharma Ophthalmic Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Pharma Ophthalmic Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Pharma Ophthalmic Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Pharma Ophthalmic Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Pharma Ophthalmic Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Pharma Ophthalmic Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Pharma Ophthalmic Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Pharma Ophthalmic Sales Share by Company (2018-2024)
Table 29. Global Pharma Ophthalmic Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Pharma Ophthalmic Revenue Share by Company (2018-2024)
Table 31. Global Market Pharma Ophthalmic Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Pharma Ophthalmic Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Pharma Ophthalmic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharma Ophthalmic as of 2022)
Table 35. Date of Key Manufacturers Enter into Pharma Ophthalmic Market
Table 36. Key Manufacturers Pharma Ophthalmic Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Pharma Ophthalmic Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Pharma Ophthalmic Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Pharma Ophthalmic Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Pharma Ophthalmic Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Pharma Ophthalmic Sales Market Share in Value by Region (2018-2024)
Table 43. Global Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Pharma Ophthalmic Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Pharma Ophthalmic Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Pharma Ophthalmic Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Pharma Ophthalmic Sales Market Share in Value by Region (2024-2034)
Table 48. Global Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Pharma Ophthalmic Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Pharma Ophthalmic Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Pharma Ophthalmic Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Pharma Ophthalmic Sales Market Share in Value by Application (2018-2024)
Table 54. Global Pharma Ophthalmic Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Pharma Ophthalmic Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Pharma Ophthalmic Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Pharma Ophthalmic Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Pharma Ophthalmic Sales Market Share in Value by Application (2024-2034)
Table 59. Global Pharma Ophthalmic Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Pharma Ophthalmic Sales by Application (2018-2024) (K Pcs)
Table 61. North America Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Pharma Ophthalmic Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Pharma Ophthalmic Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Pharma Ophthalmic Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Pharma Ophthalmic Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Pharma Ophthalmic Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Pharma Ophthalmic Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Pharma Ophthalmic Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Pharma Ophthalmic Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Pharma Ophthalmic Sales Market Share in Value by Country (2018-2024)
Table 74. North America Pharma Ophthalmic Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Pharma Ophthalmic Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Pharma Ophthalmic Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Pharma Ophthalmic Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Pharma Ophthalmic Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Pharma Ophthalmic Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Pharma Ophthalmic Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Pharma Ophthalmic Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Pharma Ophthalmic Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Pharma Ophthalmic Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Pharma Ophthalmic Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Pharma Ophthalmic Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Pharma Ophthalmic Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Pharma Ophthalmic Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Pharma Ophthalmic Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Pharma Ophthalmic Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Pharma Ophthalmic Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Pharma Ophthalmic Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Pharma Ophthalmic Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Pharma Ophthalmic Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Pharma Ophthalmic Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Pharma Ophthalmic Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Pharma Ophthalmic Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Pharma Ophthalmic Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Pharma Ophthalmic Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Pharma Ophthalmic Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Pharma Ophthalmic Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Pharma Ophthalmic Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Pharma Ophthalmic Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Pharma Ophthalmic Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Country (2024-2034)
Table 110. Novartis Company Information
Table 111. Novartis Introduction and Business Overview
Table 112. Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Novartis Pharma Ophthalmic Product
Table 114. Novartis Recent Development
Table 115. Allergan Company Information
Table 116. Allergan Introduction and Business Overview
Table 117. Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Allergan Pharma Ophthalmic Product
Table 119. Allergan Recent Development
Table 120. Roche Company Information
Table 121. Roche Introduction and Business Overview
Table 122. Roche Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Roche Pharma Ophthalmic Product
Table 124. Roche Recent Development
Table 125. Valeant Company Information
Table 126. Valeant Introduction and Business Overview
Table 127. Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Valeant Pharma Ophthalmic Product
Table 129. Valeant Recent Development
Table 130. Regeneron Company Information
Table 131. Regeneron Introduction and Business Overview
Table 132. Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Regeneron Pharma Ophthalmic Product
Table 134. Regeneron Recent Development
Table 135. Santen Company Information
Table 136. Santen Introduction and Business Overview
Table 137. Santen Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Santen Pharma Ophthalmic Product
Table 139. Santen Recent Development
Table 140. Bayer Company Information
Table 141. Bayer Introduction and Business Overview
Table 142. Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Bayer Pharma Ophthalmic Product
Table 144. Bayer Recent Development
Table 145. Pfizer Company Information
Table 146. Pfizer Introduction and Business Overview
Table 147. Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Pfizer Pharma Ophthalmic Product
Table 149. Pfizer Recent Development
Table 150. Senju Company Information
Table 151. Senju Introduction and Business Overview
Table 152. Senju Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Senju Pharma Ophthalmic Product
Table 154. Senju Recent Development
Table 155. Akorn Company Information
Table 156. Akorn Introduction and Business Overview
Table 157. Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Akorn Pharma Ophthalmic Product
Table 159. Akorn Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Pharma Ophthalmic Market Trends
Table 163. Pharma Ophthalmic Market Drivers
Table 164. Pharma Ophthalmic Market Challenges
Table 165. Pharma Ophthalmic Market Restraints
Table 166. Pharma Ophthalmic Distributors List
Table 167. Pharma Ophthalmic Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Ophthalmic Product Picture
Figure 2. Global Pharma Ophthalmic Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pharma Ophthalmic Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pharma Ophthalmic Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Retinal disorders drugs
Figure 6. Global Retinal disorders drugs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Allergic, inflammatory and infective drugs
Figure 8. Global Allergic, inflammatory and infective drugs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Glaucoma drugs
Figure 10. Global Glaucoma drugs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Dry eye drugs
Figure 12. Global Dry eye drugs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Other ophthalmic drugs
Figure 14. Global Other ophthalmic drugs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Pharma Ophthalmic Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Pharma Ophthalmic Sales Market Share by Type in 2022 & 2034
Figure 17. North America Pharma Ophthalmic Sales Market Share in Volume by Type in 2022
Figure 18. North America Pharma Ophthalmic Sales Market Share in Value by Type in 2022
Figure 19. Europe Pharma Ophthalmic Sales Market Share in Volume by Type in 2022
Figure 20. Europe Pharma Ophthalmic Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Type in 2022
Figure 23. Latin America Pharma Ophthalmic Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Pharma Ophthalmic Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Pharma Ophthalmic Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharma Ophthalmic Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharma Ophthalmic Revenue in 2022
Figure 29. Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Glaucoma
Figure 31. Global Glaucoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Dry eye syndrome
Figure 33. Global Dry eye syndrome Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Retinal diseases
Figure 35. Global Retinal diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Other ophthalmic indications
Figure 37. Global Other ophthalmic indications Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Pharma Ophthalmic Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Pharma Ophthalmic Sales Market Share by Application in 2022 & 2034
Figure 40. North America Pharma Ophthalmic Sales Market Share in Volume by Application in 2022
Figure 41. North America Pharma Ophthalmic Sales Market Share in Value by Application in 2022
Figure 42. Europe Pharma Ophthalmic Sales Market Share in Volume by Application in 2022
Figure 43. Europe Pharma Ophthalmic Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Application in 2022
Figure 46. Latin America Pharma Ophthalmic Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Pharma Ophthalmic Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Pharma Ophthalmic Manufacturing Cost Structure
Figure 51. Pharma Ophthalmic Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries